Comparison of msp genotyping and a 24 SNP molecular assay for differentiating Plasmodium falciparum recrudescence from reinfection

BACKGROUND: Current World Health Organization guidelines for conducting anti-malarial drug efficacy clinical trials recommend genotyping Plasmodium falciparum genes msp1 and msp2 to distinguish recrudescence from reinfection. A more recently developed potential alternative to this method is a molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fulakeza, Joseph, McNitt, Sarah, Vareta, Jimmy, Saidi, Alex, Mvula, Godfrey, Taylor, Terrie, Mathanga, Don P., Small, Dylan S., Skarbinski, Jacek, Gutman, Julie R., Seydel, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423793/
https://www.ncbi.nlm.nih.gov/pubmed/30885193
http://dx.doi.org/10.1186/s12936-019-2695-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423793/
https://www.ncbi.nlm.nih.gov/pubmed/30885193
http://dx.doi.org/10.1186/s12936-019-2695-0

Ejemplares similares